menu ☰
menu ˟

HEPLISAV-B vaccine safe, effective against HBV in patients with type 2 diabetes

11 Jun 2016
Adults with type 2 diabetes mellitus, who are more susceptible to hepatitis B virus infection than individuals without diabetes, had significantly higher rates of protection against the virus after receiving two doses of the investigational HEPLISAV-...

Click here to view the full article which appeared in Infectious Disease

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.